In 2005, Ostrakhovitch et al. demonstrated that activation of p53 played a crucial role in copper and zinc-induced generation of ROS in epithelial breast cancer cells via its target genes such as p53-induced gene 3 product (PIG3) and BAX [309]. The gene discussed is TP53; the disease is breast carcinoma.